Gnann H - Search Results

1

Minimal disease activity is a stable measure of therapeutic response in psoriatic arthritis patients receiving treatment with adalimumab.

Behrens F, Koehm M, Schwaneck EC, Schmalzing M, Gnann H, Greger G, Tony HP, Burkhardt H. Behrens F, et al. Among authors: gnann h. Rheumatology (Oxford). 2018 Nov 1;57(11):1938-1946. doi: 10.1093/rheumatology/key203. Rheumatology (Oxford). 2018. PMID: 30010891 Free PMC article.

2

Addition or removal of concomitant methotrexate alters adalimumab effectiveness in rheumatoid arthritis but not psoriatic arthritis.

Behrens F, Koehm M, Schwaneck EC, Schmalzing M, Wittig BM, Gnann H, Greger G, Tony HP, Burkhardt H. Behrens F, et al. Among authors: gnann h. Scand J Rheumatol. 2019 Sep;48(5):375-382. doi: 10.1080/03009742.2019.1600717. Epub 2019 Jul 16. Scand J Rheumatol. 2019. PMID: 31311386

3

Impact of patient and disease characteristics on therapeutic success during adalimumab treatment of patients with rheumatoid arthritis: data from a German noninterventional observational study.

Kleinert S, Tony HP, Krause A, Feuchtenberger M, Wassenberg S, Richter C, Röther E, Spieler W, Gnann H, Wittig BM. Kleinert S, et al. Among authors: gnann h. Rheumatol Int. 2012 Sep;32(9):2759-67. doi: 10.1007/s00296-011-2033-5. Epub 2011 Aug 6. Rheumatol Int. 2012. PMID: 21822659 Free PMC article.

4

Development and validation of a new disease activity score in 28 joints-based treatment response criterion for rheumatoid arthritis.

Behrens F, Tony HP, Alten R, Kleinert S, Scharbatke EC, Köhm M, Gnann H, Tams J, Greger G, Burkhardt H. Behrens F, et al. Among authors: gnann h. Arthritis Care Res (Hoboken). 2013 Oct;65(10):1608-16. doi: 10.1002/acr.22037. Arthritis Care Res (Hoboken). 2013. PMID: 23609999 Free article.

5

The impact of prior biologic therapy on adalimumab response in patients with rheumatoid arthritis.

Feuchtenberger M, Kleinert S, Scharbatke EC, Gnann H, Behrens F, Wittig BM, Greger G, Tony HP. Feuchtenberger M, et al. Among authors: gnann h. Clin Exp Rheumatol. 2015 May-Jun;33(3):321-9. Epub 2015 Apr 14. Clin Exp Rheumatol. 2015. PMID: 25897681

6

Association of Improvement in Pain With Therapeutic Response as Determined by Individual Improvement Criteria in Patients With Rheumatoid Arthritis.

Scharbatke EC, Behrens F, Schmalzing M, Koehm M, Greger G, Gnann H, Burkhardt H, Tony HP. Scharbatke EC, et al. Among authors: gnann h. Arthritis Care Res (Hoboken). 2016 Nov;68(11):1607-1615. doi: 10.1002/acr.22884. Epub 2016 Oct 1. Arthritis Care Res (Hoboken). 2016. PMID: 26990995 Free PMC article.

7

Anti-citrullinated protein antibodies are linked to erosive disease in an observational study of patients with psoriatic arthritis.

Behrens F, Koehm M, Thaçi D, Gnann H, Greger G, Maria Wittig B, Burkhardt H. Behrens F, et al. Among authors: gnann h. Rheumatology (Oxford). 2016 Oct;55(10):1791-5. doi: 10.1093/rheumatology/kew229. Epub 2016 Jun 21. Rheumatology (Oxford). 2016. PMID: 27330166 Free PMC article.

8

Use of a "critical difference" statistical criterion improves the predictive utility of the Health Assessment Questionnaire-Disability Index score in patients with rheumatoid arthritis.

Behrens F, Koehm M, Schwaneck EC, Schmalzing M, Gnann H, Greger G, Tony HP, Burkhardt H. Behrens F, et al. Among authors: gnann h. BMC Rheumatol. 2019 Dec 10;3:51. doi: 10.1186/s41927-019-0095-2. eCollection 2019. BMC Rheumatol. 2019. PMID: 31867564 Free PMC article.

9

Sustained improvement in work outcomes in employed patients with rheumatoid arthritis during 2 years of adalimumab therapy: an observational cohort study.

Behrens F, Tony HP, Koehm M, Schwaneck EC, Gnann H, Greger G, Burkhardt H, Schmalzing M. Behrens F, et al. Among authors: gnann h. Clin Rheumatol. 2020 Sep;39(9):2583-2592. doi: 10.1007/s10067-020-05038-y. Epub 2020 Mar 23. Clin Rheumatol. 2020. PMID: 32206973 Free PMC article.

10

Does concomitant methotrexate confer clinical benefits in patients treated with prior biologic therapy? Analysis of data from a noninterventional study of rheumatoid arthritis patients initiating treatment with adalimumab.

Schmalzing M, Behrens F, Schwaneck EC, Koehm M, Greger G, Gnann H, Burkhardt H, Tony HP. Schmalzing M, et al. Among authors: gnann h. Medicine (Baltimore). 2020 May;99(19):e20201. doi: 10.1097/MD.0000000000020201. Medicine (Baltimore). 2020. PMID: 32384515 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

36 results

Search Page

Filters